The pancreatic cancer cell cycle, viability, and apoptosis of the disease are all impacted by NF-κB transcriptionally inhibiting ErbB2 expression, as demonstrated by data from Chinese patients with PC [17]. This evidence concerns the gene NFKB1 and familial pancreatic carcinoma.